A detailed history of Three Bridge Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Three Bridge Wealth Advisors, LLC holds 12,408 shares of NVO stock, worth $1.05 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
12,408
Previous 12,694 2.25%
Holding current value
$1.05 Million
Previous $1.81 Million 18.44%
% of portfolio
0.55%
Previous 0.72%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $34,054 - $41,590
-286 Reduced 2.25%
12,408 $1.48 Million
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $40,003 - $47,892
-326 Reduced 2.5%
12,694 $1.81 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $89,550 - $119,201
-877 Reduced 6.31%
13,020 $1.67 Million
Q4 2023

Feb 08, 2024

SELL
$87.78 - $105.45 $125,613 - $150,898
-1,431 Reduced 9.34%
13,897 $1.44 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $683,505 - $1.5 Million
7,516 Added 96.21%
15,328 $1.39 Million
Q2 2023

Jul 28, 2023

SELL
$155.98 - $172.65 $209,013 - $231,351
-1,340 Reduced 14.64%
7,812 $1.26 Million
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $489,260 - $588,340
-3,697 Reduced 28.77%
9,152 $1.46 Million
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $86,347 - $113,947
-842 Reduced 6.15%
12,849 $1.74 Million
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $22,104 - $27,127
-232 Reduced 1.78%
12,790 $1.27 Million
Q2 2022

Nov 10, 2022

BUY
$103.24 - $121.81 $1.34 Million - $1.59 Million
13,022 New
13,022 $1.45 Million
Q1 2022

Feb 14, 2023

BUY
$93.1 - $112.54 $83,883 - $101,398
901 Added 7.04%
13,691 $1.53 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Three Bridge Wealth Advisors, LLC Portfolio

Follow Three Bridge Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Three Bridge Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Three Bridge Wealth Advisors, LLC with notifications on news.